Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients
October 24, 2017 09:24 ET
|
Transplant Genomics Inc.
Mansfield, Oct. 24, 2017 (GLOBE NEWSWIRE) -- MANSFIELD, MA – Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, announces a publication...
Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And Advanced Chronic Kidney Disease
June 08, 2015 21:12 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, June 8, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; USOTC: MBLTY) today announced that results from the Company's Phase 2 trial in patients with diabetic...